Sister chromatid exchange and micronucleus studies in patients with Behçet's disease

Journal of Cutaneous Pathology

Volumn 36, Issue 8, 2009, Pages 831-837

  Karaman, Ali ^a,c   Kadi, Melek ^a   Kara, Fatih ^b  

^a Department of Medical Genetics ^*  (Turkey)

^b ATATURK UNIVERSITY   (Turkey)

^c Erzurum Numune Hastanesi   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; BEHCET DISEASE; CHROMOSOMAL INSTABILITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DNA DAMAGE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HUMAN CELL CULTURE; LYMPHOCYTE; MALE; MICRONUCLEUS; NEUTROPHIL; OXIDATIVE STRESS; PATHOGENESIS; SISTER CHROMATID EXCHANGE;

ADULT; BEHCET SYNDROME; BLOOD SEDIMENTATION; DNA DAMAGE; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; LYMPHOCYTES; MALE; MALONDIALDEHYDE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; OXIDATIVE STRESS; SISTER CHROMATID EXCHANGE; SUPEROXIDE DISMUTASE;

EID: 67650655700     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2008.01180.x     Document Type: Article

References (47)

1. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 1999 341 : 1284.
2. Yazici H, Yurdakul S, Hamuryudan V. Behçet disease. Curr Opin Rheumatol 2001 13 : 18.
3. Jacobs DS, Foster CS. Bewhçet's disease. In Albert DM, Jacobiec FA, eds. Principles and practice of ophthalmology. Philadelphia : WB Saunders, 1994 3126.
4. Lehner T. The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet's disease. Int Rev Immunol 1997 14 : 21.
5. Gul A. Behçet's disease: an update on pathogenesis. Clin Exp Rheumatol 2001 19 : S6.
6. Pronai L, Ichikawa Y, Nakazawa H, Arimoy S. Enhanced superoxide generation and the decreased superoxide scavenging activity of peripheral blood leukocytes in Behçet's disease - effects of colchicine. Clin Exp Rheumatol 1991 9 : 227.
7. Dèer O, Örem A, Akyol N, Bahadir S, Yildirmiş S. PMN elestase levels in patients with Behçet's disease. Clin Chim Acta 1995 236 : 129.
8. Wilson DM III., Thompson LM. Molecular mechanisms of sister chromatid exchange. Mutat Res 2007 616 : 11.
9. Latt SA. Sister chromatid exchange formation. Annu Rev Genet 1981 15 : 11.
10. Kirsch-Volders M, Sofuni T, Aardema M, et al. Report from the in vitro micronucleus assay working group. Mutat Res 2003 540 : 153.
11. Fenech M. The in vitro micronucleus technique. Mutat Res 2000 455 : 81.
12. Reiter RJ. Free radicals, melatonin, and cellular antioxidative defence mechanisms. Path Immun Neuroendocrin Comm Cir 1994 35 : 135.
13. Bunkler VA. Free radicals, antioxidants and ageing. Med Lab Sci 1992 49 : 299.
14. Bonnes-Tourel D, Guerin MC, Torreilles J. Is malondialdehyde a valuable indicator of lipid peroxidation? Biochem Pharmacol 1992 44 : 985.
15. Draper HH, McGirr LG, Hadley M. The metabolism of malondialdehyde. Lipids 1986 21 : 305.
16. Bengtsson A, Lundberg M, Avila-Carino J, et al. Thiols decrease cytokine levels and down-regulate the expression of CD30 on human allergen-specific T helper (Th) 0 and TH2 cells. Clin Exp Immunol 2001 123 : 350.
17. Interrnational Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990 335 : 1078.
18. Latt SA, Schreck RR. Sister chromatid exchange analysis. Am J Hum Genet 1980 32 : 297.
19. Fenech M, Morley AA. Measurement of micronuclei in lymphocytes. Mutat Res 1985 147 : 29.
20. Pompella A, Maellora E, Casini AF, Ferrali M, Ciccoli L, Comporti M. Measurement of lipid peroxidation in vivo: a comparison of different procedures. Lipids 1987 22 : 206.
21. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988 34 : 497.
22. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967 70 : 158.
23. Kotter I, Günaydin I, Stubiger N, et al. Comparative analysis of the association of HLA*51 suballeles with Behçet's disease in patients of German and Turkish origin. Tissue Antigens 2001 58 : 168.
24. Zouboulis CC, May T. Pathogenesis of Adamantiades-Behçet's disease. Med Microbiol Immunol 2003 192 : 149.
25. Sohn S, Lee ES, lee S. The correlation of MHC haplotype and development of Behçet's disease-like symptoms induced by herpes simplex virus in several inbred mouse strains. J Dermatol Sci 2001 20 : 173.
26. Ghate JV, Jorizzo JL. Behçet's disease and complex aphthosis. J Am Acad Dermatol 1999 40 : 1.
27. Sahin S, Akòlu T, Direskeneli H, Sen LS, Lawrence R. Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease. Ann Rheum Dis 1996 55 : 128.
28. Takeno M, Kariyone A, Yamashita N, et al. Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum 1995 38 : 426.
29. Guemouri L, Artur Y, Herbeth B, Jeadel C, Siest G. Biological variability of superoxide dismutase, glutathione peroxidase, and catalase in blood. Clin Chem 1991 37 : 1932 1937. (Pubitemid 121000148)
30. Önder M, Gürer MA. The multiple faces of Behçet's disease and its aetiological factors. J Eur Acad Dermatol Venereol 2000 15 : 126.
31. Köse K, Dòan P, Asciòlu M, Asciòlu O. In vitro antioxidant effect of Ginkgo biloba extract (Egb 761) on lipoperoxidation induced by hydrogen peroxide in erythrocytes of Behçet's patients. Jpn J Pharmacol 1997 75 : 253.
32. Limoli CL, Giedzinski E, Morgan WF, et al. Persistent oxidative stress in chromosomally unstable cells. Cancer Res 2003 63 : 3107.
33. 2-induced higher order chromatin degradation: a novel mechanism of oxidative genotoxicity. J Biosci 2003 28 : 57.
34. Norppa H. Cytogenetic biomarkers. IARC Sci Publ 2004 157 : 179.
35. Norppa H, Bonassi S, Hansteen I-L, et al. Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutat Res 2006 600 : 37.
36. Fenech M, Holland N, Chang WP, Zeiger E, Bonassi S. The Human MicroNucleus Project: an international collaborative study on the use of micronucleus technique for measuring DNA damage in humans. Mutat Res 1999 428 : 29.
37. Van Delft JHM, Baan RA, Roza L. Biological effect markers for exposure to carcinogenic compound and their relevance for risk assessment. Crit Rev Toxicol 1998 28 : 477.
38. Sönmez S, kaya M, Aktaş A, Ikbal M, Senel K. High frequency of sister chromatid exchanges in lymphocytes of the patients with Behçet's disease. Mutat Res 1998 397 : 235.
39. Ikbal M, Atasoy M, Pirim I, Aliàaòlu C, Karatay S, Erdem T. The alteration of sister chromatid exchange frequencies in Behçet's disease with and without HLA-B51. J Eur Acad Dermatol Venereol 2006 20 : 149.
40. Hamurcu Z, Dönmez-Altuntaş H, Borlu M, Demirtaş H, Ascioslu Ö. Micronucleus frequency in the oral mucosa and lymphocytes of patients with Behçet's disease. Clin Exp Dermatol 2005 30 : 565.
41. Bashir S, Harris G, Denman MA. Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann Rheum Dis 1993 52 : 659.
42. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med 1991 91 : 14.
43. Örem A, Efe H, Dèer O, Cimsit G, Uydu HA, Vanizor B. Relationship between lipid peroxidation and disease activity in patients with Behçet's disease. J Dermatol Sci 1997 16 : 11.
44. Köse K, Yazici C, Aşciòlu O. The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Behçet's disease. Clin Biochem 2001 34 : 125.
45. Tüzün A, Aydin A, Turan M. Erythrocyte antioxidant activity and trace element levels in Behçet's disease. Biol Trace Elem Res 1998 64 : 169.
46. Köse K, Yazici C, Çambay N, Aşçiòlu Ö, Dòan P. Lipid peroxidation and erythrocyte antioxidant enzymes in patients with Behçet's disease. Tohoku J Exp Med 2002 197 : 9.
47. Erkiliç K, Everekliòlu C, Çekmen M, Özkiriş A, Duygulu F, Dòan H. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations. Mediators Inflamm 2003 12 : 107.